ASO Author Reflections: The Whole Transcriptome Landscape of Circulating Tumor Cells in Nonmetastatic Breast Cancer.
作者信息
Lang Julie E, Brownson Kirstyn E
机构信息
Section of Breast, Endocrine and Soft Tissue Surgery, Department of Surgery and Norris Cancer Center, University of Southern California, Los Angeles, CA, USA.
出版信息
Ann Surg Oncol. 2018 Dec;25(Suppl 3):646-647. doi: 10.1245/s10434-018-6888-5. Epub 2018 Oct 11.
Abstract
摘要
相似文献
1
ASO Author Reflections: The Whole Transcriptome Landscape of Circulating Tumor Cells in Nonmetastatic Breast Cancer.ASO作者反思：非转移性乳腺癌中循环肿瘤细胞的全转录组图谱
Ann Surg Oncol. 2018 Dec;25(Suppl 3):646-647. doi: 10.1245/s10434-018-6888-5. Epub 2018 Oct 11.
2
ASO Author Reflections: Advancing Circulating Tumor Cells as Liquid Biopsies to Efficiently Target Metastatic Breast Cancer.ASO作者反思：推动循环肿瘤细胞作为液体活检技术以有效靶向转移性乳腺癌
Ann Surg Oncol. 2022 May;29(5):2895-2896. doi: 10.1245/s10434-021-11139-y. Epub 2021 Dec 1.
3
The prognostic value of circulating tumor cells in patients with breast cancer.循环肿瘤细胞在乳腺癌患者中的预后价值。
Surg Gynecol Obstet. 1962 Sep;115:291-4.
4
ASO Author Reflections: Metastatic Biopsy of Osteosarcoma with Circulating RNA.ASO作者反思：骨肉瘤伴循环RNA的转移活检
Ann Surg Oncol. 2018 Dec;25(Suppl 3):936-937. doi: 10.1245/s10434-018-6977-5. Epub 2018 Nov 19.
5
Circulating Tumor Cells and Radiotherapy Benefit in Early Breast Cancer-Reply.循环肿瘤细胞与早期乳腺癌放疗获益——回复
JAMA Oncol. 2019 Jan 1;5(1):112. doi: 10.1001/jamaoncol.2018.5108.
6
Techniques and Thresholds for Quantifying Circulating Tumor Cells in Breast Cancer.乳腺癌循环肿瘤细胞定量分析的技术与阈值
JAMA Oncol. 2019 Apr 1;5(4):573-574. doi: 10.1001/jamaoncol.2018.7217.
7
Circulating Tumor Cells and Radiotherapy Benefit in Early Breast Cancer.循环肿瘤细胞与早期乳腺癌的放疗获益
JAMA Oncol. 2019 Jan 1;5(1):111-112. doi: 10.1001/jamaoncol.2018.5077.
8
Techniques and Thresholds for Quantifying Circulating Tumor Cells in Breast Cancer-In Reply.乳腺癌中循环肿瘤细胞定量的技术与阈值——回复
JAMA Oncol. 2019 Apr 1;5(4):574. doi: 10.1001/jamaoncol.2018.7236.
9
Circulating tumor cell count could be used to determine treatment of metastatic breast cancer.循环肿瘤细胞计数可用于确定转移性乳腺癌的治疗方案。
Cancer. 2019 Apr 1;125(7):1021. doi: 10.1002/cncr.32050.
10
Circulating miRNAs as surrogate markers for circulating tumor cells and prognostic markers in metastatic breast cancer.循环 miRNA 作为循环肿瘤细胞的替代标志物和转移性乳腺癌的预后标志物。
Clin Cancer Res. 2012 Nov 1;18(21):5972-82. doi: 10.1158/1078-0432.CCR-12-1407. Epub 2012 Sep 4.
本文引用的文献
1
RNA-Seq of Circulating Tumor Cells in Stage II-III Breast Cancer.循环肿瘤细胞在 II-III 期乳腺癌中的 RNA-Seq 分析。
Ann Surg Oncol. 2018 Aug;25(8):2261-2270. doi: 10.1245/s10434-018-6540-4. Epub 2018 Jun 4.
2
The potential for liquid biopsies in the precision medical treatment of breast cancer.液体活检在乳腺癌精准医疗中的潜力。
Cancer Biol Med. 2016 Mar;13(1):19-40. doi: 10.28092/j.issn.2095-3941.2016.0007.
3
Circulating tumor cells and response to chemotherapy in metastatic breast cancer: SWOG S0500.循环肿瘤细胞与转移性乳腺癌的化疗反应：SWOG S0500研究
J Clin Oncol. 2014 Nov 1;32(31):3483-9. doi: 10.1200/JCO.2014.56.2561. Epub 2014 Jun 2.
4
Circulating tumour cells in non-metastatic breast cancer: a prospective study.非转移性乳腺癌中的循环肿瘤细胞：一项前瞻性研究。
Lancet Oncol. 2012 Jul;13(7):688-95. doi: 10.1016/S1470-2045(12)70209-7. Epub 2012 Jun 6.
5
Circulating tumor cells, disease progression, and survival in metastatic breast cancer.循环肿瘤细胞、疾病进展与转移性乳腺癌患者的生存情况
N Engl J Med. 2004 Aug 19;351(8):781-91. doi: 10.1056/NEJMoa040766.
6
The evolution of paradigms for the management of breast cancer: a personal perspective.乳腺癌管理模式的演变：个人观点。
Cancer Res. 1992 May 1;52(9):2371-83.
Zotero 插件